Who Should Be Prioritized for Scarce Medical Assistance?

Publication Date

1-21-2022

Document Type

Article

Organizational Units

Sturm College of Law

Keywords

Public health, Bioethics, COVID, Antivirals

Abstract

As we enter 2022, the challenge of fairly allocating scarce medical capacity in response to the COVID-19 pandemic continues. New oral antivirals are available, but in short supply. The omicron variant has heightened the scarcity of monoclonal antibodies as two other frequently used antibody therapies are ineffective against it. And medical personnel are overstretched.

Copyright Statement / License for Reuse

All Rights Reserved
All Rights Reserved.

Publication Statement

User is responsible for all copyright compliance.



Share

COinS